An investigation for investors in NASDAQ:HNSN shares was announced concerning whether the takeover of Hansen Medical, Inc. by Auris Surgical Robotics, Inc is unfair.
Investors who purchased shares of Hansen Medical, Inc. (NASDAQ:HNSN) and currently hold any of those NASDAQ:HNSN shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain directors of Hansen Medical, Inc. breached their fiduciary duties owed to NASDAQ:HNSN investors in connection with the proposed acquisition.
On April 20, 2016, Auris Surgical Robotics, Inc. and Hansen Medical, Inc. (NASDAQ:HNSN) announced that they have signed a merger agreement under which Auris will acquire Hansen Medical, Inc. (NASDAQ:HNSN) for $4.00 per share in cash, or a total equity value of approximately $80 million.
However, given that certain holders of approximately 65.4% of Hansen Medical’s outstanding shares have already entered into voting agreements with Auris Surgical Robotics, Inc and Hansen Medical pursuant to which they have agreed to vote in favor of and otherwise support the transaction, the investigation concerns whether the offer is unfair to NASDAQ:HNSN stockholders. More specifically, the investigation concerns whether the Hansen Medical Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders’ best interests in connection with the proposed sale.
Shares of Hansen Medical, Inc. (NASDAQ:HNSN) closed on May 12, 2016, at $4.00 per share.
Those who are current investors in NASDAQ:HNSN shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com